DelveInsight's "Tendonitis Market Insights, Epidemiology, and Market Forecast 2032" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Tendonitis market size and shares analysis in the seven major markets (7MM).
The report also covers emerging therapies, current treatment practices, Tendonitis Market Shares of the individual therapies, a detailed current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.
Tendonitis: An Overview
Tendonitis is an inflammation of a tendon – a thick, flexible cord of tissue that attaches muscles to bone and assists in moving the bone or structure. Tendonitis most commonly occurs in the shoulder, bicep, elbow, hand, wrist, thumb, calf, knee, or ankle. Since the pain of tendonitis occurs near a joint, it is sometimes mistaken for arthritis. The condition is more common in adults over the age of 40 and athletes. Some forms of tendonitis are named after certain sports (e.g., tennis elbow, golfer’s elbow, pitcher’s shoulder, swimmer’s shoulder, and jumper’s knee).
Tendonitis may go away over time. If not, the doctor will recommend treatments to reduce pain and inflammation and preserve mobility. Severe symptoms may require specialized treatment from a rheumatologist, an orthopedic surgeon, or a physical therapist. When adequately treated, most tendinitis conditions do not result in permanent joint damage or disability. Treatment options include RICE (Rest, Ice, Compression, Elevation); physical or occupational therapy; Splints, braces, or slings – these assistive devices allow the affected area to rest until the pain eases; over-the-counter (OTC) and prescription medicines; and corticosteroids injections.
Tendonitis Key Facts and Studies
- In the 7MM, the Tendonitis incident cases were 11.71 Million (M) in the year 2020, which is expected to grow in the coming years.
- In the 7MM, the total treated cases of Tendonitis were 5.47 M cases in the year 2020.
- In 2020, the total Gender-specific cases of Tendonitis were 8.04 M (male) and 3.68 M (Female) in the 7MM.
- In the US, the total Region-specific Cases of Tendonitis were (2.15 M) Achilles Tendonitis, (0.95 M) Patellar tendonitis, and (1.67 M) other cases in the year 2020.
- In the US, the total Gender-specific cases of Tendonitis were 3.34 M cases (male) and 1.43 M cases (female) in the year 2020.
- According to Kevin (2019), Achilles tendinopathy is the most common tendinopathy of the lower limb. It accounts for 55–65% of Achilles tendon pathologies. Its impact was 1.85/1,000 in the general population and 2.35/1,000 among people aged 21–60 years. It is found preferentially in sports endurance (in 50% of cases).
The Tendonitis Market is expected to grow significantly owing to an increase in the targeted patient pool and Novel treatment approaches.
Tendonitis Market Outlook
The Tendonitis market analysis section of the report helps to understand the current and forecasted Tendonitis Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers. The report gives complete detail of Tendonitis Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Tendonitis Therapeutics Market
As per the secondary domain searches and exploring clinical trials sites, it has been observed that a number of clinical trials had been registered for Tendonitis. Globally, some of the key players are involved in the development of therapies for Tendonitis, expected to launch in the coming years.
Some of the key companies in the Tendonitis Market include:
- R3 Stem Cell
- Orthocell
- Novartis
- MiMedX group
- InGeneron
- TRB Chemedica
And many more
Tendonitis Therapies covered in the report include:
- AmnioFix
- Secukinumab
- Ortho-ATI
- Amniotic stem cells
- Adipose-derived regenerative cells (ADRC)
And many more
Tendonitis Market Drivers
- Increase in the targeted patient pool
- Novel treatment approaches
Tendonitis Pipeline Insights
The Tendonitis Pipeline and Drugs Uptake section focus on the rate of uptake of the market therapies as well as the therapies expected to get launch in the coming years. The analysis covers the Tendonitis Market uptake by drugs, patient uptake by therapies, and drug sales. Report’s drugs uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the Tendonitis Therapies based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Report Insights
- Pipeline Analysis
- Market Opportunities
- Impact of upcoming Therapies
- Tendonitis Patient Population
- Tendonitis Market Size and Trends
- Tendonitis Therapeutic Approaches
For more details, visit: Tendonitis Market Size Analysis